tiprankstipranks
Karyopharm Therapeutics (KPTI)
NASDAQ:KPTI
US Market
KPTI
Karyopharm Therapeutics
RESEARCH TOOLSreports
Want to see KPTI full AI Analyst Report?

Karyopharm Therapeutics (KPTI) Income Statement

1,229 Followers

Karyopharm Therapeutics Income Statement

Last quarter (Q4 2025), Karyopharm Therapeutics's total revenue was $34.08M, an increase of 11.58% from the same quarter last year. In Q4, Karyopharm Therapeutics's net income was $-102.20M. See Karyopharm Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 146.07M$ 145.24M$ 146.03M$ 157.07M$ 209.82M
Gross Profit
$ 140.12M$ 139.23M$ 141.09M$ 151.86M$ 206.42M
Operating Expenses
$ 230.82M$ 258.67M$ 270.63M$ 294.06M$ 304.69M
Depreciation and Amortization
$ 296.00K$ 340.00K$ 530.00K$ 621.00K$ 789.00K
EBITDA
$ -90.41M$ -38.60M$ -118.42M$ -139.31M$ -96.98M
Operating Income
$ -90.71M$ -119.44M$ -129.54M$ -142.20M$ -98.27M
Other Income/Expenses
$ -105.29M$ 43.08M$ -13.24M$ -22.72M$ -25.55M
Pretax Income
$ -196.00M$ -76.36M$ -142.78M$ -164.92M$ -123.82M
Net Income
$ -196.04M$ -76.42M$ -143.10M$ -165.29M$ -124.09M
Per Share Metrics
Basic EPS
$ -17.93$ -9.41$ -18.79$ -30.28$ -24.75
Diluted EPS
$ -17.93$ -9.41$ -18.79$ -30.28$ -24.75
Weighted Average Shares Outstanding
 10.94M 8.12M 7.61M 5.46M 5.01M
Weighted Average Shares Outstanding (Diluted)
 10.94M 8.12M 7.61M 5.46M 5.01M
Currency in USD

Karyopharm Therapeutics Earnings and Revenue History